Hildebrandt R H, Rouse R V, Longacre T A
Division of Surgical Pathology, Stanford University Medical Center, CA 94305, USA.
Hum Pathol. 1997 Dec;28(12):1387-95. doi: 10.1016/s0046-8177(97)90229-x.
Inhibins are peptide hormones that participate in the regulation of the pituitary-gonadal feedback system and are selectively expressed by cells of sex cord-stromal derivation. To determine the efficacy of this marker for distinguishing granulosa cell tumors, 134 primary and metastatic lesions of the ovary were evaluated for expression of the alpha-subunit of inhibin in routinely processed formalin-fixed, paraffin-embedded tissue. A variety of sex cord-stromal tumors (SCST), including 35 adult and juvenile granulosa cell tumors, 14 fibroma-thecomas, and 18 other sex cord-stromal proliferations, were studied. In addition, 33 surface epithelial neoplasms, 12 germ cell tumors, 11 metastases, and 11 miscellaneous ovarian neoplastic proliferations were evaluated. Among the non-granulosa cell neoplasms, special emphasis was placed on primary neoplasms and metastases that histologically simulated granulosa cell tumors. Thirty-three of 35 (94%) granulosa cell tumors were immunoreactive compared with 2 of 12 (17%) primary ovarian endometrioid tumors, one of nine (11%) primary ovarian transitional cell (Brenner) proliferations, and 3 of 17 (18%) other primary and metastatic poorly differentiated (undifferentiated) carcinomas. In 31 of the 35 granulosa cell tumors, inhibin staining was of moderate to strong intensity or was present in at least half of the constituent cells, whereas only 2 of 33 primary surface epithelial neoplasms fulfilled the same criteria, showing weak staining of 70% to 80% of the cells. In contrast, 10 of 14 (71%) ovarian fibroma-thecomas and 17 of 18 (94%) other sex cord-stromal proliferations were positive for inhibin. Nonneoplastic luteinized stromal cells stained for inhibin in 29 of 85 cases in which they could be evaluated. The results of this study show that although it is not completely specific and cannot reliably distinguish granulosa cell tumors from fibroma-thecomas or other ovarian sex cord-stromal proliferations, inhibin can be used to help distinguish sex cord-stromal neoplasms from most primary and metastatic non-SCST. Caution should be exercised in the interpretation of inhibin-positive cells, because a wide variety of primary and metastatic ovarian tumors may contain significant numbers of positively staining luteinized cells.
抑制素是一种肽类激素,参与垂体 - 性腺反馈系统的调节,且由性索 - 间质来源的细胞选择性表达。为了确定该标志物在鉴别颗粒细胞瘤中的效能,我们在常规处理的福尔马林固定、石蜡包埋组织中,对134例卵巢原发性和转移性病变进行了抑制素α亚基表达的评估。研究了多种性索 - 间质肿瘤(SCST),包括35例成人和青少年颗粒细胞瘤、14例纤维瘤 - 卵泡膜细胞瘤以及18例其他性索 - 间质增生。此外,还评估了33例表面上皮性肿瘤、12例生殖细胞肿瘤、11例转移瘤以及11例其他卵巢肿瘤性增生。在非颗粒细胞瘤中,特别关注了组织学上模拟颗粒细胞瘤的原发性肿瘤和转移瘤。35例颗粒细胞瘤中有33例(94%)呈免疫反应性,相比之下,12例原发性卵巢子宫内膜样肿瘤中有2例(17%)、9例原发性卵巢移行细胞(布伦纳)增生中有1例(11%)以及17例其他原发性和转移性低分化(未分化)癌中有3例(18%)呈免疫反应性。在35例颗粒细胞瘤中的31例中,抑制素染色呈中度至强强度,或至少在半数组成细胞中存在,而33例原发性表面上皮性肿瘤中只有2例符合相同标准,表现为70%至80%的细胞呈弱阳性染色。相比之下,14例卵巢纤维瘤 - 卵泡膜细胞瘤中有10例(71%)以及18例其他性索 - 间质增生中有17例(94%)抑制素呈阳性。在85例可评估的非肿瘤性黄素化间质细胞中,有29例抑制素染色阳性。本研究结果表明,尽管抑制素并不完全特异,也不能可靠地将颗粒细胞瘤与纤维瘤 - 卵泡膜细胞瘤或其他卵巢性索 - 间质增生区分开来,但它可用于帮助将性索 - 间质肿瘤与大多数原发性和转移性非SCST区分开来。在解释抑制素阳性细胞时应谨慎,因为多种原发性和转移性卵巢肿瘤可能含有大量阳性染色的黄素化细胞。